TransMedics Group, Inc. (TMDX)
71.59
+0.81
(+1.14%)
USD |
NASDAQ |
Oct 19, 16:00
71.59
0.00 (0.00%)
After-Hours: 16:13
TransMedics Group Cash from Operations (Annual) : 192.84M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 192.84M |
| December 31, 2024 | 48.80M |
| December 31, 2023 | -13.03M |
| December 31, 2022 | -45.82M |
| December 31, 2021 | -28.86M |
| Date | Value |
|---|---|
| December 31, 2020 | -30.26M |
| December 31, 2019 | -32.29M |
| December 31, 2018 | -25.98M |
| December 31, 2017 | -23.10M |
| December 31, 2016 | -24.19M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Boston Scientific Corp. | 4.534B |
| Abbott Laboratories | 9.566B |
| Alphatec Holdings, Inc. | 45.23M |
| Baxter International, Inc. | 845.00M |
| Becton, Dickinson & Co. | 3.43B |